CA3292803A1 - Dérivés de naphtyridinone pour le traitement d'une maladie ou d'un trouble - Google Patents

Dérivés de naphtyridinone pour le traitement d'une maladie ou d'un trouble

Info

Publication number
CA3292803A1
CA3292803A1 CA3292803A CA3292803A CA3292803A1 CA 3292803 A1 CA3292803 A1 CA 3292803A1 CA 3292803 A CA3292803 A CA 3292803A CA 3292803 A CA3292803 A CA 3292803A CA 3292803 A1 CA3292803 A1 CA 3292803A1
Authority
CA
Canada
Prior art keywords
disorder
disease
treatment
naphthyridinone derivatives
naphthyridinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3292803A
Other languages
English (en)
Inventor
Atwood Cheung
Donglei Liu
Stefan Peukert
John Trauger
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA3292803A1 publication Critical patent/CA3292803A1/fr
Pending legal-status Critical Current

Links

CA3292803A 2023-05-24 2024-05-22 Dérivés de naphtyridinone pour le traitement d'une maladie ou d'un trouble Pending CA3292803A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/504,099 2023-05-24

Publications (1)

Publication Number Publication Date
CA3292803A1 true CA3292803A1 (fr) 2024-11-28

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024228957A1 (en) Hydroquinazoline derivatives for the treatment of a disease or disorder
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
AU2024211867A1 (en) 1-amino-4-phenylphthalazine derivatives useful for the treatment of neurodegenerative diseases
EP4069251A4 (fr) Sels et polymorphes de céthromycine pour le traitement de sels et de polymorphes de céthromycine
IL312689A (en) Naphthyridinone derivatives for the treatment of a disease or disorder
EP4217355A4 (fr) Agents pour le traitement de maladies par inhibition de foxo1
CA3292803A1 (fr) Dérivés de naphtyridinone pour le traitement d'une maladie ou d'un trouble
CA3284390A1 (fr) Dérivés d'hydroquinazoline pour le traitement d'une maladie ou d'un trouble
SI4436662T1 (sl) Derivativi nafthiridinona za zdravljenje bolezni ali motnje
HK40117635A (en) Rifamycin derivatives for the treatment of diseases
HK40083363A (en) A pharmaceutical combination for the treatment of a cancer
CA3279062A1 (fr) Dérivés de 1-amino-4-phénylphtalazine utiles pour le traitement de maladies neurodégénératives
HK40083228A (en) Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
CA3283434A1 (fr) Diaminophénothiazine pour le traitement de maladies microvasculaires du cerveau
HK40130956A (zh) 用於治疗眼部病症的药物缀合物
CA3278714A1 (fr) Conjugués médicamenteux pour le traitement de troubles oculaires
HK40129437A (en) Drug conjugates for the treatment of ocular disorders
CA3291083A1 (fr) Polythérapie pour une maladie ou un trouble lié à ras
HK40086640A (en) Method for the treatment nlrp3-associated diseases
HK40131570A (zh) 用於治疗疾病的基於酞嗪酮的调节剂
HK40081973A (en) Combination treatment for fumarate-related diseases
HK40119944A (en) Use of niraparib for the treatment of brain cancer
CA3272161A1 (fr) Composés de probénécide pour le traitement d'affections dermatologiques médiées par l'inflammasome
AU2021902938A0 (en) Fitting Patients for Neuromodulation Therapy
AU2022902097A0 (en) Treatment for joint disorders